NM_014141.6:c.208+3841G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.208+3841G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 152,006 control chromosomes in the GnomAD database, including 16,525 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 16525 hom., cov: 33)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.643

Publications

4 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.208+3841G>A
intron
N/ANP_054860.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.208+3841G>A
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000625365.2
TSL:5
c.208+3841G>A
intron
N/AENSP00000485955.1
CNTNAP2
ENST00000636277.1
TSL:5
n.75+3841G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
63950
AN:
151888
Hom.:
16478
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.733
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.351
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.372
Gnomad FIN
AF:
0.389
Gnomad MID
AF:
0.321
Gnomad NFE
AF:
0.279
Gnomad OTH
AF:
0.403
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.421
AC:
64055
AN:
152006
Hom.:
16525
Cov.:
33
AF XY:
0.421
AC XY:
31298
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.733
AC:
30402
AN:
41472
American (AMR)
AF:
0.277
AC:
4237
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.351
AC:
1213
AN:
3458
East Asian (EAS)
AF:
0.424
AC:
2191
AN:
5166
South Asian (SAS)
AF:
0.374
AC:
1794
AN:
4802
European-Finnish (FIN)
AF:
0.389
AC:
4103
AN:
10538
Middle Eastern (MID)
AF:
0.341
AC:
99
AN:
290
European-Non Finnish (NFE)
AF:
0.279
AC:
18944
AN:
67976
Other (OTH)
AF:
0.401
AC:
846
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1632
3264
4896
6528
8160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.373
Hom.:
1586
Bravo
AF:
0.425
Asia WGS
AF:
0.396
AC:
1375
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
2.6
DANN
Benign
0.39
PhyloP100
0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10244837; hg19: chr7-146475314; API